Express News | MiMedx Publishes First Study In Top Journal Highlighting Regulatory Capabilities Of DHACM And LHACM Allografts On Fibrosis; Expands Understanding Of Fibrotic Process
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
Express News | Cassava Sciences Inc: Renewal of Quarterly Analyst Calls
Express News | Cassava Sciences Inc: Ongoing Phase 3 Trials Are Being Run According to FDA and Industry Standards
Express News | Cassava Sciences Inc: Is Reviewing Its Disclosure Practices to Ensure It Is Providing Stakeholders With Clear and Comprehensive Information
Express News | Cassava Sciences Inc: Co and Burns Agreed That She Step Down From Her Role, Effective Immediately
Express News | Cassava Sciences Inc: Lindsay Burns Is Also Leaving Employ of Company
Express News | Cassava Sciences Inc: Initiates Search for a New CEO
Express News | Cassava Sciences Inc -Remi Barbier Resigns as President and CEO and From Board of Directors
Express News | Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
MiMedx Group, Inc.'s (NASDAQ:MDXG) Share Price Is Matching Sentiment Around Its Revenues
Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes
Cantor Starts MiMedx at Overweight, Cites Valuation, Product Offerings
MiMedx Group Initiated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Initiates MiMedx(MDXG.US) With Buy Rating, Announces Target Price $11
Express News | MiMedx Announces the Appointment of Kim Moller to Chief Commercial Officer
Press Release: MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
With 45% Ownership, MiMedx Group, Inc. (NASDAQ:MDXG) Has Piqued the Interest of Institutional Investors
Wound Skin Substitutes Market Global Analysis to 2030, Featuring Coloplast, Smith & Nephew, MTF Biologics, MiMedx, AlloSource, Organogenesis, RTI Surgical, LifeNet Health and Molecular Biologicals